Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
Key facts
- Where
- Detroit, United StatesSee the site
Where in United States
- Henry Ford HealthDetroit, United StatesContact: Matthew MelicanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Henry Ford Health System
- Trial code
- NCT06269510
- Record updated
- 3 February 2026
- Original description
The purpose of this trial is to see if providing patients with alcohol-related liver disease with tailored alcohol use treatment options will increase engagement with treatment and correct possible misconceptions.Read full original descriptionShow less
Enhancing Alcohol Treatment Engagement in ALD Patients
The purpose of this trial is to see if providing patients with alcohol-related liver disease with tailored alcohol use treatment options will increase engagement with treatment and correct possible misconceptions.
Inclusion: Willingness to comply with all study procedures and availability for the duration of the study; Willing and able to provide informed consent; Enrolled at University of Michigan (UM) hepatology clinics or inpatients at UM Hospitals; Documented diagnosis of alcohol-related liver disease (ALD) (per protocol); Recent alcohol use of any amount within the past 6 months as assessed by either patient interview, medical chart review, or positive alcohol biomarker (e.g. blood alcohol level, urinary ethyl glucuronide, urinary ethyl sulfate, or phosphatidylethanol) in the medical record; No alcohol use treatment within the past 1 month including, but not limited to:; Any professionally lead therapy with a mental health counselor (such as, one-on-one therapy, group therapy, couples or family therapy) with a primary aim of alcohol abstinence or reduction in alcohol use; Community-based alcohol recovery groups (such as, Alcoholics Anonymous, SMART Recovery, Celebrate Recovery, Refuge Recovery); Community-based church support groups primarily focused on alcohol abstinence or reduction in use; Residential (inpatient) alcohol treatment; Intensive outpatient programs; Any telehealth version of the above options; Access to a Smartphone or computer for purposes of follow-up. Those who do not have a Smartphone will be provided one along with a calling/data plan at no cost to subject by the study team for the duration of the research stud; Ability to speak and comprehend English.
Exclusion: Undergoing active evaluation for liver transplantation, is listed for liver transplant, or is post-transplantation; History of nonadherence to previous clinical or research studies; Substantially cognitively impaired as evidenced by Westhaven grade 2 or higher hepatic encephalopathy or a score >=10 on the Short Blessed Test for cognitive impairment; Any other medical condition or circumstance that precludes safe and meaningful participation in the study; Unable to provide voluntary informed consent for any reason; Unable to read or understand English; Is enrolled in the multidisciplinary ALD clinic at Michigan Medicine.